Full-length HLA-G1 and truncated HLA-G3 differentially increase HLA-E surface localization

Human Immunology

Volumn 73, Issue 9, 2012, Pages 898-905

  Teklemariam, Takele ^a   Zhao, Longmei ^a   Hantash, Basil M ^a  

^a Escape Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA E ANTIGEN; HLA G1 ANTIGEN; HLA G3 ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; BIOTINYLATION; FLOW CYTOMETRY; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL MEMBRANE; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-G ANTIGENS; HUMANS; K562 CELLS; PROTEIN TRANSPORT;

EID: 84865361367     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.06.007     Document Type: Article

References (53)

1. Braud V.M., Allan D.S., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L., McMichael A.J. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998, 391(6669):795.
2. Braud V.M., Allan D.S., Wilson D., McMichael A.J. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr Biol 1998, 8(1):1.
3. Tomasec P., Braud V.M., Rickards C., Powell M.B., McSharry B.P., Gadola S., Cerundolo V., Borysiewicz L.K., McMichael A.J., Wilkinson G.W. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000, 287(5455):1031.
4. Borrego F., Ulbrecht M., Weiss E.H., Coligan J.E., Brooks A.G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 1998, 187(5):813.
5. Weiss E.H., Lilienfeld B.G., Muller S., Muller E., Herbach N., Kessler B., Wanke R., Schwinzer R., Seebach J.D., Wolf E., Brem G. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity. Transplantation 2009, 87(1):35.
6. King A., Allan D.S., Bowen M., Powis S.J., Joseph S., Verma S., Hiby S.E., McMichael A.J., Loke Y.W., Braud V.M. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol 2000, 30(6):1623.
7. Li J., Goldstein I., Glickman-Nir E., Jiang H., Chess L. Induction of TCR Vbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E. J Immunol 2001, 167(7):3800.
8. Ulbrecht M., Modrow S., Srivastava R., Peterson P.A., Weiss E.H. Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation. J Immunol 1998, 160(9):4375.
9. Sarantopoulos S., Lu L., Cantor H. Qa-1 restriction of CD8+ suppressor T cells. J Clin Invest 2004, 114(9):1218.
10. Romagnani C., Pietra G., Falco M., Millo E., Mazzarino P., Biassoni R., Moretta A., Moretta L., Mingari M.C. Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells. Proc Natl Acad Sci U S A 2002, 99(17):11328.
11. Moreau P., Rousseau P., Rouas-Freiss N., Le Discorde M., Dausset J., Carosella E.D. HLA-G protein processing and transport to the cell surface. Cell Mol Life Sci 2002, 59(9):1460.
12. Carosella E.D., Dausset J., Kirszenbaum M. HLA-G revisited. Immunol Today 1996, 17(9):407.
13. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990, 248(4952):220.
14. Wischhusen J., Waschbisch A., Wiendl H. Immune-refractory cancers and their little helpers-an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?. Semin Cancer Biol 2007, 17(6):459.
15. Le Discorde M., Moreau P., Sabatier P., Legeais J.M., Carosella E.D. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 2003, 64(11):1039.
16. Donadi EA, Castelli EC, Arnaiz-Villena A, Roger M, Rey D, Moreau P: Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci 68(3):369.
17. Rouas-Freiss N., Marchal R.E., Kirszenbaum M., Dausset J., Carosella E.D. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?. Proc Natl Acad Sci U S A 1997, 94(10):5249.
18. Rouas-Freiss N., Goncalves R.M., Menier C., Dausset J., Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A 1997, 94(21):11520.
19. Riteau B., Rouas-Freiss N., Menier C., Paul P., Dausset J., Carosella E.D. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 2001, 166(8):5018.
20. Bahri R., Hirsch F., Josse A., Rouas-Freiss N., Bidere N., Vasquez A., Carosella E.D., Charpentier B., Durrbach A. Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes. J Immunol 2006, 176(3):1331.
21. LeMaoult J., Caumartin J., Daouya M., Favier B., Le Rond S., Gonzalez A., Carosella E.D. Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 2007, 109(5):2040.
22. Caumartin J., Favier B., Daouya M., Guillard C., Moreau P., Carosella E.D., LeMaoult J. Trogocytosis-based generation of suppressive NK cells. EMBO J 2007, 26(5):1423.
23. Horuzsko A., Lenfant F., Munn D.H., Mellor A.L. Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol 2001, 13(3):385.
24. Riteau B., Menier C., Khalil-Daher I., Sedlik C., Dausset J., Rouas-Freiss N., Carosella E.D. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 1999, 43(2):203.
25. Lila N., Amrein C., Guillemain R., Chevalier P., Latremouille C., Fabiani J.N., Dausset J., Carosella E.D., Carpentier A. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002, 105(16):1949.
26. Lila N., Carpentier A., Amrein C., Khalil-Daher I., Dausset J., Carosella E.D. Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000, 355(9221):2138.
27. Rouas-Freiss N., LeMaoult J., Moreau P., Dausset J., Carosella E.D. HLA-G in transplantation: a relevant molecule for inhibition of graft rejection?. Am J Transplant 2003, 3(1):11.
28. Sheu J.J. Shih Ie M: Clinical and biological significance of HLA-G expression in ovarian cancer. Semin Cancer Biol 2007, 17(6):436.
29. Ulbrecht M., Maier S., Hofmeister V., Falk C.S., Brooks A.G., McMaster M.T., Weiss E.H. Truncated HLA-G isoforms are retained in the endoplasmic reticulum and insufficiently provide HLA-E ligands. Hum Immunol 2004, 65(3):200.
30. Matsunami K., Miyagawa S., Nakai R., Murase A., Shirakura R. The possible use of HLA-G1 and G3 in the inhibition of NK cell-mediated swine endothelial cell lysis. Clin Exp Immunol 2001, 126(1):165.
31. Polakova K., Kuba D., Russ G. The 4H84 monoclonal antibody detecting beta2m free nonclassical HLA-G molecules also binds to free heavy chains of classical HLA class I antigens present on activated lymphocytes. Hum Immunol 2004, 65(2):157.
32. Polakova K., Bennink J.R., Yewdell J.W., Bystricka M., Bandzuchova E., Russ G. Mild acid treatment induces cross-reactivity of 4H84 monoclonal antibody specific to nonclassical HLA-G antigen with classical HLA class I molecules. Hum Immunol 2003, 64(2):256.
33. Wiendl H., Mitsdoerffer M., Hofmeister V., Wischhusen J., Bornemann A., Meyermann R., Weiss E.H., Melms A., Weller M. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J Immunol 2002, 168(9):4772.
34. McMaster M., Zhou Y., Shorter S., Kapasi K., Geraghty D., Lim K.H., Fisher S. HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation. J Immunol 1998, 160(12):5922.
35. Ravindranath M.H., Taniguchi M., Chen C.W., Ozawa M., Kaneku H., El-Awar N., Cai J., Terasaki P.I. HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies. Mol Immunol 2009, 47(5):1121.
36. Chen X., Allan D.S., Krzewski K., Ge B., Kopcow H., Strominger J.L. CD28-stimulated ERK2 phosphorylation is required for polarization of the microtubule organizing center and granules in YTS NK cells. Proc Natl Acad Sci U S A 2006, 103(27):10346.
37. Menier C., Saez B., Horejsi V., Martinozzi S., Krawice-Radanne I., Bruel S., Le Danff C., Reboul M., Hilgert I., Rabreau M., Larrad M.L., Pla M., Carosella E.D., Rouas-Freiss N. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules. Hum Immunol 2003, 64(3):315.
38. Lo Monaco E., Sibilio L., Melucci E., Tremante E., Suchanek M., Horejsi V., Martayan A., Giacomini P. HLA-E: strong association with beta2-microglobulin and surface expression in the absence of HLA class I signal sequence-derived peptides. J Immunol 2008, 181(8):5442.
39. Lo Monaco E., Tremante E., Cifaldi L., Fruci D., Giacomini P. HLA-E and the origin of immunogenic self HLA epitopes. Mol Immunol 2010, 47(9):1661.
40. Ravindranath M.H., Taniguchi M., Chen C.W., Ozawa M., Kaneku H., El-Awar N., Cai J., Terasaki P.I. HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies. Mol Immunol 2000, 47(5):1121.
41. Paul P., Rouas-Freiss N., Moreau P., Cabestre F.A., Menier C., Khalil-Daher I., Pangault C., Onno M., Fauchet R., Martinez-Laso J., Morales P., Villena A.A., Giacomini P., Natali P.G., Frumento G., Ferrara G.B., McMaster M., Fisher S., Schust D., Ferrone S., Dausset J., Geraghty D., Carosella E.D. HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. Hum Immunol 2000, 61(11):1177.
42. Khalil-Daher I., Riteau B., Menier C., Sedlik C., Paul P., Dausset J., Carosella E.D., Rouas-Freiss N. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself. J Reprod Immunol 1999, 43(2):175.
43. Riteau B., Menier C., Khalil-Daher I., Martinozzi S., Pla M., Dausset J., Carosella E.D., Rouas-Freiss N. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol 2001, 13(2):193.
44. *0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line. Immunogenetics 2004, 56(9):617.
45. Shiroishi M., Kuroki K., Rasubala L., Tsumoto K., Kumagai I., Kurimoto E., Kato K., Kohda D., Maenaka K. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci U S A 2006, 103(44):16412.
46. Blobel G., Dobberstein B. Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma. J Cell Biol 1975, 67(3):835.
47. Paetzel M., Dalbey R.E., Strynadka N.C. Crystal structure of a bacterial signal peptidase in complex with a beta-lactam inhibitor. Nature 1998, 396(6707):186.
48. Lemberg M.K., Bland F.A., Weihofen A., Braud V.M., Martoglio B. Intramembrane proteolysis of signal peptides: an essential step in the generation of HLA-E epitopes. J Immunol 2001, 167(11):6441.
49. Neefjes J.J., Momburg F. Cell biology of antigen presentation. Curr Opin Immunol 1993, 5(1):27.
50. Shaikly V., Shakhawat A., Withey A., Morrison I., Taranissi M., Dealtry G.B., Jabeen A., Cherry R., Fernandez N. Cell bio-imaging reveals co-expression of HLA-G and HLA-E in human preimplantation embryos. Reprod Biomed Online 2010, 20(2):223.
51. Tripathi P., Agrawal S. The role of human leukocyte antigen E and G in HIV infection. AIDS 2007, 21(11):1395.
52. Nattermann J., Nischalke H.D., Hofmeister V., Kupfer B., Ahlenstiel G., Feldmann G., Rockstroh J., Weiss E.H., Sauerbruch T., Spengler U. HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells. Antivir Ther 2005, 10(1):95.
53. Matsunami K., Miyagawa S., Nakai R., Yamada M., Shirakura R. Modulation of the leader peptide sequence of the HLA-E gene up-regulates its expression and down-regulates natural killer cell-mediated swine endothelial cell lysis. Transplantation 2002, 73(10):1582.